SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-074243
Filing Date
2024-06-17
Accepted
2024-06-17 16:12:31
Documents
11
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dsgn-20240613.htm   iXBRL 8-K 49229
  Complete submission text file 0000950170-24-074243.txt   170150

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dsgn-20240613.xsd EX-101.SCH 26967
14 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20240613_htm.xml XML 5111
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 241048345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)